Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: Assessment of existent risk scores

Benjamin Zendejas, Tanya L. Hoskin, Amy C Degnim, Carol A. Reynolds, David R. Farley, Judy C Boughey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Patients with metastases in four or more axillary lymph nodes (≥4+ALN) represent a subset of patients with breast cancer who are at increased risk of local recurrence and who benefit from postmastectomy radiation. Risk prediction models designed to identify such patients have been published by Rivers et al., Chagpar et al., and Katz et al. We sought to evaluate and compare the performance of these models in an independent patient population. Methods: We reviewed 454 patients with breast cancer with one to three positive sentinel lymph nodes who underwent completion axillary lymph node dissection at our institution. Each of the three published models was applied to our sample as described in the respective publications. The models' performances were analyzed with the Hosmer-Lemeshow goodness-of-fit test and with the area under the curve (AUC). Sensitivity, specificity, and false-negative percentages were calculated for clinically meaningful cutoff points of each score. Results: Of 454 eligible patients, 87 (19.2%) had four or more positive axillary nodes. The Rivers, Chagpar, and Katz models demonstrated good calibration in our population based on the Hosmer-Lemeshow test (p = 0.82, p = 0.73, p = 0.71, respectively). Assessment of discriminatory ability for the models resulted in AUCs of 0.81, 0.73, and 0.81, respectively. Conclusions: The Rivers and Katz models performed well in our patient population and may be clinically useful to predict patients with ≥4+ALN. However, their clinical utility is limited by the current controversy surrounding the use of postmastectomy radiation for all node-positive patients.

Original languageEnglish (US)
Pages (from-to)2884-2891
Number of pages8
JournalAnnals of Surgical Oncology
Volume17
Issue number11
DOIs
StatePublished - Nov 2010

Fingerprint

Lymph Nodes
Breast Neoplasms
Rivers
Area Under Curve
Radiation
Population
cyhalothrin
Lymph Node Excision
Calibration
Publications
Neoplasm Metastasis
Recurrence
Sensitivity and Specificity

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer : Assessment of existent risk scores. / Zendejas, Benjamin; Hoskin, Tanya L.; Degnim, Amy C; Reynolds, Carol A.; Farley, David R.; Boughey, Judy C.

In: Annals of Surgical Oncology, Vol. 17, No. 11, 11.2010, p. 2884-2891.

Research output: Contribution to journalArticle

@article{d48206124dfe4371821ca68293cdcca4,
title = "Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: Assessment of existent risk scores",
abstract = "Background: Patients with metastases in four or more axillary lymph nodes (≥4+ALN) represent a subset of patients with breast cancer who are at increased risk of local recurrence and who benefit from postmastectomy radiation. Risk prediction models designed to identify such patients have been published by Rivers et al., Chagpar et al., and Katz et al. We sought to evaluate and compare the performance of these models in an independent patient population. Methods: We reviewed 454 patients with breast cancer with one to three positive sentinel lymph nodes who underwent completion axillary lymph node dissection at our institution. Each of the three published models was applied to our sample as described in the respective publications. The models' performances were analyzed with the Hosmer-Lemeshow goodness-of-fit test and with the area under the curve (AUC). Sensitivity, specificity, and false-negative percentages were calculated for clinically meaningful cutoff points of each score. Results: Of 454 eligible patients, 87 (19.2{\%}) had four or more positive axillary nodes. The Rivers, Chagpar, and Katz models demonstrated good calibration in our population based on the Hosmer-Lemeshow test (p = 0.82, p = 0.73, p = 0.71, respectively). Assessment of discriminatory ability for the models resulted in AUCs of 0.81, 0.73, and 0.81, respectively. Conclusions: The Rivers and Katz models performed well in our patient population and may be clinically useful to predict patients with ≥4+ALN. However, their clinical utility is limited by the current controversy surrounding the use of postmastectomy radiation for all node-positive patients.",
author = "Benjamin Zendejas and Hoskin, {Tanya L.} and Degnim, {Amy C} and Reynolds, {Carol A.} and Farley, {David R.} and Boughey, {Judy C}",
year = "2010",
month = "11",
doi = "10.1245/s10434-010-1077-1",
language = "English (US)",
volume = "17",
pages = "2884--2891",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer

T2 - Assessment of existent risk scores

AU - Zendejas, Benjamin

AU - Hoskin, Tanya L.

AU - Degnim, Amy C

AU - Reynolds, Carol A.

AU - Farley, David R.

AU - Boughey, Judy C

PY - 2010/11

Y1 - 2010/11

N2 - Background: Patients with metastases in four or more axillary lymph nodes (≥4+ALN) represent a subset of patients with breast cancer who are at increased risk of local recurrence and who benefit from postmastectomy radiation. Risk prediction models designed to identify such patients have been published by Rivers et al., Chagpar et al., and Katz et al. We sought to evaluate and compare the performance of these models in an independent patient population. Methods: We reviewed 454 patients with breast cancer with one to three positive sentinel lymph nodes who underwent completion axillary lymph node dissection at our institution. Each of the three published models was applied to our sample as described in the respective publications. The models' performances were analyzed with the Hosmer-Lemeshow goodness-of-fit test and with the area under the curve (AUC). Sensitivity, specificity, and false-negative percentages were calculated for clinically meaningful cutoff points of each score. Results: Of 454 eligible patients, 87 (19.2%) had four or more positive axillary nodes. The Rivers, Chagpar, and Katz models demonstrated good calibration in our population based on the Hosmer-Lemeshow test (p = 0.82, p = 0.73, p = 0.71, respectively). Assessment of discriminatory ability for the models resulted in AUCs of 0.81, 0.73, and 0.81, respectively. Conclusions: The Rivers and Katz models performed well in our patient population and may be clinically useful to predict patients with ≥4+ALN. However, their clinical utility is limited by the current controversy surrounding the use of postmastectomy radiation for all node-positive patients.

AB - Background: Patients with metastases in four or more axillary lymph nodes (≥4+ALN) represent a subset of patients with breast cancer who are at increased risk of local recurrence and who benefit from postmastectomy radiation. Risk prediction models designed to identify such patients have been published by Rivers et al., Chagpar et al., and Katz et al. We sought to evaluate and compare the performance of these models in an independent patient population. Methods: We reviewed 454 patients with breast cancer with one to three positive sentinel lymph nodes who underwent completion axillary lymph node dissection at our institution. Each of the three published models was applied to our sample as described in the respective publications. The models' performances were analyzed with the Hosmer-Lemeshow goodness-of-fit test and with the area under the curve (AUC). Sensitivity, specificity, and false-negative percentages were calculated for clinically meaningful cutoff points of each score. Results: Of 454 eligible patients, 87 (19.2%) had four or more positive axillary nodes. The Rivers, Chagpar, and Katz models demonstrated good calibration in our population based on the Hosmer-Lemeshow test (p = 0.82, p = 0.73, p = 0.71, respectively). Assessment of discriminatory ability for the models resulted in AUCs of 0.81, 0.73, and 0.81, respectively. Conclusions: The Rivers and Katz models performed well in our patient population and may be clinically useful to predict patients with ≥4+ALN. However, their clinical utility is limited by the current controversy surrounding the use of postmastectomy radiation for all node-positive patients.

UR - http://www.scopus.com/inward/record.url?scp=78049464651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049464651&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-1077-1

DO - 10.1245/s10434-010-1077-1

M3 - Article

C2 - 20429038

AN - SCOPUS:78049464651

VL - 17

SP - 2884

EP - 2891

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 11

ER -